Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
Research shows that Blacks may develop multiple sclerosis more often than previously thought. Additionally, the symptoms of ...
MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...
A new study from Norway found a 42% lower risk of developing MS among women with greater dietary vitamin D intake, ...
NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...
News-Medical.Net on MSN
Rare immune events link Epstein Barr virus to early multiple sclerosis damage
The current study shows that the Epstein–Barr virus can interfere with the normal control of B cells. One viral protein ...
The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...
Many women with multiple sclerosis (MS) notice a worsening of symptoms or progression just as menopause begins. While getting older is linked with disease progression in both men and women, hormones ...
Immunoglobulin G oligoclonal bands in CSF are highly prevalent in MS and CIS, with positive status associated with a significantly earlier age of disease onset.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback